1. Kim, Young-Mi, Kim, Hye-Youn, Ha Thi, Huyen Trang, Kim, Seong-Jin, Hong, Suntaek. 2023. Pellino 3 promotes the colitis-associated colorectal cancer through suppression of IRF4-mediated negative regulation of TLR4 signalling. In Molecular oncology, 17, 2380-2395. doi:10.1002/1878-0261.13475. https://pubmed.ncbi.nlm.nih.gov/37341064/
2. El-Shal, Amal S, Matboli, Marwa, Abdelaziz, Ahmed M, Morsy, Ali A, Abdelbary, Eman H. 2019. Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer. In IUBMB life, 71, 2031-2047. doi:10.1002/iub.2153. https://pubmed.ncbi.nlm.nih.gov/31520466/
3. Giegerich, Annika Klara, Kuchler, Laura, Sha, Lisa Katharina, Brüne, Bernhard, von Knethen, Andreas. 2014. Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression. In Autophagy, 10, 1937-52. doi:10.4161/auto.32178. https://pubmed.ncbi.nlm.nih.gov/25483963/
4. He, Yu-Zheng, Li, Xiao-Ning, Li, Hai-Tao, Zhao, Xiu-Min, Li, Shuai. 2024. FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer. In Pulmonary pharmacology & therapeutics, 87, 102317. doi:10.1016/j.pupt.2024.102317. https://pubmed.ncbi.nlm.nih.gov/39154901/
5. Yu, Yi, Wagner, Erin K, Souied, Eric H, Daly, Mark J, Seddon, Johanna M. . Protective coding variants in CFH and PELI3 and a variant near CTRB1 are associated with age-related macular degeneration†. In Human molecular genetics, 25, 5276-5285. doi:10.1093/hmg/ddw336. https://pubmed.ncbi.nlm.nih.gov/28011711/
6. Bustamante, Marta F, Morcillo-Suárez, Carlos, Malhotra, Sunny, Montalban, Xavier, Comabella, Manuel. 2015. Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β. In Neurology(R) neuroimmunology & neuroinflammation, 2, e154. doi:10.1212/NXI.0000000000000154. https://pubmed.ncbi.nlm.nih.gov/26445728/
7. Martínez-Aguilar, Laura, Pérez-Ramírez, Cristina, Maldonado-Montoro, María Del Mar, Ramírez-Tortosa, María Carmen, Jiménez-Morales, Alberto. 2020. Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta. In Mutation research. Reviews in mutation research, 785, 108322. doi:10.1016/j.mrrev.2020.108322. https://pubmed.ncbi.nlm.nih.gov/32800273/
8. Seddon, Johanna M, Rosner, Bernard. 2018. Validated Prediction Models for Macular Degeneration Progression and Predictors of Visual Acuity Loss Identify High-Risk Individuals. In American journal of ophthalmology, 198, 223-261. doi:10.1016/j.ajo.2018.10.022. https://pubmed.ncbi.nlm.nih.gov/30389371/
智鼠故事 
